Currect Oncology_Vol17_3_Online.indd

First Page		Document Content
Date: 2012-06-18 21:28:45 Carcinoid syndrome Radiation oncology Carcinoid Octreotide 5-Hydroxyindoleacetic acid Radiation therapy Oncology DOTA-TATE Octreotide scan Medicine Gastrointestinal cancer Neuroendocrine tumor		Currect Oncology_Vol17_3_Online.indd Add to Reading List Source URL: www.carcinoid.org Download Document from Source Website File Size: 1,43 MB Share Document on Facebook

	ORIGINAL ARTICLE A Prospective Trial on the Effect of Body Mass Index and Sex on Plasma Octreotide Levels in Patients Undergoing Long-Term Octreotide LAR Therapy Saju Joseph, MD,* Gang Li, PhD,Þ Erika Lindholm, MD,* Yi DocID: 1saQk - View Document
	ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D DocID: 1rlNJ - View Document
	JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide DocID: 1qMJM - View Document
	AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas Tracey L. Smitha,b, Ziqiang Yuanc, Marina Cardó-Vilaa,b, Carmen Sanchez Clarosc, Asha Ademc, Min-Hui DocID: 1pbhx - View Document
	ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency DocID: 1p1DF - View Document